Plain-English translation of NCT06681428 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether amniotic membrane allografts—thin, healing patches made from placental tissue—can help diabetic foot ulcers heal better than standard wound care alone. The placental tissue contains natural healing factors and structural proteins that may help wounds close faster. Researchers will compare three different versions of these tissue patches against standard bandaging over 12 weeks to see which works best.
Diabetic foot ulcers are hard to heal and can lead to serious complications like infection or amputation. Standard bandaging alone doesn't always work well enough, so doctors are looking for new treatments that use the body's natural healing power to close these wounds more effectively.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the placental tissue patches plus standard wound care, or standard wound care alone. You'll visit the study clinic once a week for 12 weeks so doctors can measure your ulcer's healing and monitor your progress. The placental tissue patches (if you receive them) are applied directly to the wound surface and changed at each visit, while standard care involves calcium alginate dressing and compression wrapping.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States